PP_1170x120_10-25-21

dutasteride

PuraCap facility gets thumbs-up from FDA

PuraCap facility gets thumbs-up from FDA

PISCATAWAY, N.J. — PuraCap Pharmaceutical LLC said the Food and Drug Administration has completed successful general inspection of its affiliated soft gelatin capsule manufacturing facility, Humanwell PuraCap Pharmaceutical (Wuhan) Co. Ltd., in Wuhan, Hubei Province, China. In addition, a pending Abbreviated New Drug Application (ANDA) for Dutasteride was recommended for approval following the successful inspection,

Teva unveils Avodart generic

Teva unveils Avodart generic

JERUSALEM — Teva Pharmaceutical Industries Ltd. has released dutasteride capsules 0.5 mg, a medication for enlarged prostate, in the United States. Teva said Monday that its product is a generic version of Avodart capsules from GlaxoSmithKline and noted that, as the first to file, it expects to be exclusive for several weeks. Dutasteride capsules are